Significant body weight reduction with cagrilintide-semaglutide therapy
1. In this randomized controlled trial, the combination cagrilintide-semaglutide (CagriSema) resulted in significantly greater body weight reduction compared to either agent alone or placebo. 2. CagriSema also demonstrated significant superiority over placebo in reducing waist circumference, lowering systolic blood pressure, and improving physical function. Evidence Rating Level: 1 (Excellent) Study Rundown: The prevalence of overweight and […]
The post Significant body weight reduction with cagrilintide-semaglutide therapy first appeared on 2 Minute Medicine.Source: 2 Minute Medicine